FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068555276> ?p ?o ?g. }

• W2068555276 endingPage "127" @default.
• W2068555276 startingPage "119" @default.
• W2068555276 abstract "A new 2-nitroimidazole nucleoside radiosensitizer, PR-350 (1-[1',3',4'-trihydroxy-2'-butoxy]-methyl-2-nitroimidazole), has been reported to be as efficient as and less toxic than etanidazole. This compound is racemic, and it was recently optically resolved into two isomers, PR-68 (2'R,3'S type) and PR-69 (2'S,3'R type). The other two isomers, PR-28 (2'S,3'S type) and PR-44 (2'R,3'R type), were asymmetrically synthesized. In the present study, we investigated the properties, sensitizing activity, and toxicity of PR-350 and the four optical isomers in comparison with those of other 2-nitroimidazole hypoxic cell radiosensitizers, etanidazole, KU-2285, KIN-804, and RP-170. Because PR-350 and PR-28 can be industrially synthesized, we evaluated whether either of these two drugs are suitable for further investigation.In an in vitro study, EMT-6 cells were irradiated at a dose of 1-3 Gy under hypoxic conditions in the presence of the drugs at a concentration of 1 mM. A combined cytokinesis-block micronucleus and chromosomal aberration assay was performed. To assess the in vivo effects, colony assay and growth delay assay were performing using SCCVII tumor-bearing C3H mice. The mice received 16-24 GY 10-40 min after administration of 50-200 mg/kg of the drugs. Toxicity and pharmacokinetics in mice were also investigated.The sensitizer enhancement ratio (SER) in the in vitro cytokinesis-block micronucleus assay increased in the following order: PR-69 (1.27) approximately equal to PR-28 (1.31) approximately equal to PR-44 (1.38) approximately equal to PR-350 (1.41) approximately equal to PR-68 (1.47) < etanidazole (1.79) < KIN-804 (2.03) approximately equal to KU-2285 (2.30). The SER at a dose of 200 mg/kg and at an interval of 20 min (optimal interval) in the in vivo-in vitro colony assay increased as follows: PR-44 (1.26) approximately equal to PR-28 (1.29) < PR-69 (1.34) approximately equal to etanidazole (1.35) approximately equal to PR-350 (1.36) < RP-170 (1.41) approximately equal to PR-68 (1.41) < KU-2285 (1.49). The growth delay assay also showed that PR-350 was less efficient than KU-2285 and more efficient than PR-28. PR-350 and the four isomers had similar reduction potentials, but PR-28 and PR-44 were more hydrophilic than PR-68 and PR-69. The LD50 in mice were 5.8 g/kg for PR-350, approximately 7 g/kg for PR-28, 4 g/kg for PR-68, and 6 g/kg for PR-44 and PR-69. The concentration of PR-28 in the murine sciatic nerve was lower than that of PR-350.In vivo radiosensitizing activity differed among the four optical isomers, which appeared to be due, at least in part, to differences in lipophilicity. Although PR-28 was the least toxic, its low sensitization efficiency does not warrant clinical trials. Among the PR compounds, PR-68 appears to be most efficient, but optical resolution of PR-68 from PR-350 is expensive, and asymmetrical synthesis of PR-68 is not established. Therefore, PR-350 seems to be most suitable for further investigation among the PR-350 series compounds, considering its higher efficiency compared with PR-28 and PR-44, and established synthesis." @default.
• W2068555276 created "2016-06-24" @default.
• W2068555276 creator A5013307791 @default.
• W2068555276 creator A5040691530 @default.
• W2068555276 creator A5050452238 @default.
• W2068555276 creator A5054458732 @default.
• W2068555276 creator A5067546830 @default.
• W2068555276 creator A5071240286 @default.
• W2068555276 creator A5078435301 @default.
• W2068555276 creator A5083293938 @default.
• W2068555276 creator A5089131283 @default.
• W2068555276 date "1995-08-01" @default.
• W2068555276 modified "2023-09-25" @default.
• W2068555276 title "Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): Radiosensitization efficiency and toxicity" @default.
• W2068555276 cites W1898209140 @default.
• W2068555276 cites W1963629383 @default.
• W2068555276 cites W1974961340 @default.
• W2068555276 cites W1978544089 @default.
• W2068555276 cites W1993642626 @default.
• W2068555276 cites W1994555849 @default.
• W2068555276 cites W2005146092 @default.
• W2068555276 cites W2018893675 @default.
• W2068555276 cites W2028160966 @default.
• W2068555276 cites W2034537619 @default.
• W2068555276 cites W2045658902 @default.
• W2068555276 cites W2047482025 @default.
• W2068555276 cites W2047646585 @default.
• W2068555276 cites W2047739398 @default.
• W2068555276 cites W2050347877 @default.
• W2068555276 cites W2051567532 @default.
• W2068555276 cites W2059232606 @default.
• W2068555276 cites W2064168107 @default.
• W2068555276 cites W2066082960 @default.
• W2068555276 cites W2085851177 @default.
• W2068555276 cites W2141575226 @default.
• W2068555276 cites W2144572512 @default.
• W2068555276 doi "https://doi.org/10.1016/0360-3016(95)00040-6" @default.
• W2068555276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7642409" @default.
• W2068555276 hasPublicationYear "1995" @default.
• W2068555276 type Work @default.
• W2068555276 sameAs 2068555276 @default.
• W2068555276 citedByCount "27" @default.
• W2068555276 countsByYear W20685552762013 @default.
• W2068555276 countsByYear W20685552762017 @default.
• W2068555276 countsByYear W20685552762019 @default.
• W2068555276 countsByYear W20685552762020 @default.
• W2068555276 countsByYear W20685552762023 @default.
• W2068555276 crossrefType "journal-article" @default.
• W2068555276 hasAuthorship W2068555276A5013307791 @default.
• W2068555276 hasAuthorship W2068555276A5040691530 @default.
• W2068555276 hasAuthorship W2068555276A5050452238 @default.
• W2068555276 hasAuthorship W2068555276A5054458732 @default.
• W2068555276 hasAuthorship W2068555276A5067546830 @default.
• W2068555276 hasAuthorship W2068555276A5071240286 @default.
• W2068555276 hasAuthorship W2068555276A5078435301 @default.
• W2068555276 hasAuthorship W2068555276A5083293938 @default.
• W2068555276 hasAuthorship W2068555276A5089131283 @default.
• W2068555276 hasConcept C112705442 @default.
• W2068555276 hasConcept C126322002 @default.
• W2068555276 hasConcept C142724271 @default.
• W2068555276 hasConcept C150903083 @default.
• W2068555276 hasConcept C177322064 @default.
• W2068555276 hasConcept C185592680 @default.
• W2068555276 hasConcept C202751555 @default.
• W2068555276 hasConcept C207001950 @default.
• W2068555276 hasConcept C2776428644 @default.
• W2068555276 hasConcept C2776543447 @default.
• W2068555276 hasConcept C2777333352 @default.
• W2068555276 hasConcept C2781047020 @default.
• W2068555276 hasConcept C2781305896 @default.
• W2068555276 hasConcept C29730261 @default.
• W2068555276 hasConcept C33070731 @default.
• W2068555276 hasConcept C36681516 @default.
• W2068555276 hasConcept C45080847 @default.
• W2068555276 hasConcept C509974204 @default.
• W2068555276 hasConcept C55493867 @default.
• W2068555276 hasConcept C71240020 @default.
• W2068555276 hasConcept C71924100 @default.
• W2068555276 hasConcept C86803240 @default.
• W2068555276 hasConcept C98274493 @default.
• W2068555276 hasConceptScore W2068555276C112705442 @default.
• W2068555276 hasConceptScore W2068555276C126322002 @default.
• W2068555276 hasConceptScore W2068555276C142724271 @default.
• W2068555276 hasConceptScore W2068555276C150903083 @default.
• W2068555276 hasConceptScore W2068555276C177322064 @default.
• W2068555276 hasConceptScore W2068555276C185592680 @default.
• W2068555276 hasConceptScore W2068555276C202751555 @default.
• W2068555276 hasConceptScore W2068555276C207001950 @default.
• W2068555276 hasConceptScore W2068555276C2776428644 @default.
• W2068555276 hasConceptScore W2068555276C2776543447 @default.
• W2068555276 hasConceptScore W2068555276C2777333352 @default.
• W2068555276 hasConceptScore W2068555276C2781047020 @default.
• W2068555276 hasConceptScore W2068555276C2781305896 @default.
• W2068555276 hasConceptScore W2068555276C29730261 @default.
• W2068555276 hasConceptScore W2068555276C33070731 @default.
• W2068555276 hasConceptScore W2068555276C36681516 @default.
• W2068555276 hasConceptScore W2068555276C45080847 @default.
• W2068555276 hasConceptScore W2068555276C509974204 @default.

• next